ModraDoc006/r in Patients With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Recurrent Breast Cancer
Interventions: DRUG: ModraDoc006/r
Sponsor: Modra Pharmaceuticals